Varian Medical Systems (VAR) Q1 2012 Earnings Call January 25, 2012 5:00 pm ET Executives Spencer R. Sias - Former Vice President of Corporate Communications & Investor Relations Dow R. Wilson - Chief Operating Officer and Corporate Executive Vice President Elisha W. Finney - Chief Financial Officer and Corporate Senior Vice President of Finance Timothy E. Guertin - Chief Executive Officer, President and Executive Director Analysts Steve Beuchaw - Morgan Stanley, Research Division Amit Bhalla - Citigroup Inc, Research Division Vivian Cervantes - Kaufman Bros., L.P., Research Division David H. Roman - Goldman Sachs Group Inc., Research Division Jeffrey D. Johnson - Robert W. Baird & Co. Incorporated, Research Division Anthony Petrone - Jefferies & Company, Inc., Research Division Jeremy Feffer - Cantor Fitzgerald & Co., Research Division Junaid Husain - Dougherty & Company LLC, Research Division Tycho W. Peterson - JP Morgan Chase & Co, Research Division Jason Wittes - Caris & Company, Inc., Research Division Dalton L. Chandler - Needham & Company, LLC, Research Division PresentationOperator
Good day, ladies and gentlemen, and welcome to the Varian Medical Systems First Quarter Fiscal Year 2012 Earnings Conference Call. My name is Cathy, and I'll be your operator for today. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. I would now like to turn the conference over to your host for today's call, Mr. Spencer Sias, Vice President of Investor Relations and Corporate Communications. Please proceed, sir. Spencer R. Sias Thank you. Good afternoon, and welcome to Varian Medical Systems conference call for the first quarter of fiscal year 2012. Participating in this call are Tim Guertin, President and CEO; Elisha Finney, CFO; Dow Wilson, Executive Vice President and Chief Operating Officer; and Tai Chen, our Corporate Controller. Tim is on travel and participating remotely. Tim and Elisha will summarize our results and will take your questions following the presentation.